期刊文献+

p53和survivin在交界性上皮性卵巢肿瘤中的表达及其临床意义 被引量:1

Expression of p53 and survivin in epithelial borderline ovarian tumors
下载PDF
导出
摘要 目的:探讨p53和survivin在交界性上皮性卵巢肿瘤中的表达及其意义以及二者的相互关系。方法:采用免疫组织化学EliVision法检测上皮性卵巢癌30例、卵巢上皮性交界性肿瘤30例和上皮性良性卵巢肿瘤30例组织中p53和survivin。结果:在良性、交界性、恶性上皮性卵巢肿瘤组织中,survivin的阳性率分别为13.33%、43.33%和86.67%,差异均有统计学意义(P<0.05);p53的阳性率分别为23.33%、36.67%和73.33%,恶性上皮性卵巢肿瘤组织中阳性率与良性和交界性比较差异有统计学意义(P<0.05~P<0.01),而良性和交界性卵巢肿瘤组织中阳性率差异无统计学意义(P>0.05);p53和survivin在交界性卵巢肿瘤组织中表达有相关性。结论:survivin与p53表达水平增高可能与交界性卵巢肿瘤的发生、发展有关,可为卵巢交界性肿瘤的诊断及预后判断提供依据,且二者在上皮性交界性卵巢肿瘤的癌变中可能存在协同作用。 Objective:To explore the expression of survivin and p53 in epithelial borderline ovarian tumors and their clinical significance and correlation.Methods:Immunohistochemical EliVision method was used to detect the expression of survivin and p53 in 30 cases of epithelial ovarian carcinomas,30 cases of epithelial borderline ovarian tumors and 30 cases of epithelial ovarian benign tumors.Results:In epithelial benign ovarian tumors,epithelial borderline ovarian tumors and epithelial ovarian carcinomas,the positive rates of survivin immunostaining were 13.33%,43.33% and 86.67%,respectively;there were significant differences among the three groups(P0.05).The positive rates of p53 were 23.33%,36.67% and 73.33%,respectively;there was statistical difference between the epithelial ovarian carcinomas and the epithelial benign or borderline ovarian tumors(P0.05-P0.01),but no statistical difference was observed between the benign ovarian tumors and the borderline ovarian tumors(P0.05).There was a positive correlation between the expression of survivin and p53 in borderline ovarian tumors(P0.05).Conclusions:Over expression of survivin and p53 suggests that they may participate in the oncogensis and progression of epithelial borderline ovarian tumors,which can provide reference for the diagnosis and prognosis of the epithelial borderline ovarian tumors.Both survivin and p53 may play an important role in the pathogenesis of epithelial borderline ovarian tumors.
出处 《蚌埠医学院学报》 CAS 2011年第10期1078-1080,1083,共4页 Journal of Bengbu Medical College
关键词 卵巢肿瘤 上皮性交界性卵巢肿瘤 SURVIVIN P53 免疫组织化学 ovarin neoplasms epithelial borderline ovarian tumor survivin p53 immunohistochemistry
  • 相关文献

参考文献8

二级参考文献25

  • 1姚宏,许彬.免疫组织化学在卵巢肿瘤及瘤样病变的最新研究进展[J].山西医药杂志,2005,34(6):446-448. 被引量:2
  • 2张生军,刘敏丽,魏晓丽.大肠癌中Survivin、Caspase 3基因的表达与生物学特性分析[J].中国现代医学杂志,2007,17(9):1073-1075. 被引量:9
  • 3Muchmore SW, Chen J ,Jakob C,et al . Crystal struclure and mutagenic analysis of the inhibitor of apoptosis protein surviving[J]. Mol Cell ,2000,6(1) :173-182.
  • 4Ambrosini G. A novel anti apoptosis gene survivin expressed in cancer and lymphoma[J]. J Nat Med ,1997,3(8):917.
  • 5Cohen C, Lohmann CM, Cotsonis G, et al. Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis[J]. Mod Pathol , 2003,16 (6) : 574-583.
  • 6AMBROSINI G, ADIDA C, ALRIERI DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma[J]. Nature Med, 1999, 3(8): 917-921.
  • 7TAMM I, WANG Y, SAUSVILLE E, et al. IAP-family protein survivin inhibits easpase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs[J]. Cancer Res, 1998, 58(23): 5315-5320.
  • 8LI F, AMBROSINI G, CHU EY, et al. Control of apoptosis and mitotic spindle checkpoint by survivin [J]. Nature, 1998, 396 (6711): 580-584.
  • 9TERLIKOWSKI S, LENCZEWSKI A, FAMULSKI W, et al. Patterns of hyperplastic endometrium and Cytobiol, 2001, 39 (Suppl 2): staining for p53 expression in adenocareinoma[J]. Folia Histoehem 195-196.
  • 10PAQUETTE RL, LEE YY, WILCZYNSKI SP, et al. Mutations of p53 and human papillomavirus infection in cervical carcinoma[J]. Cancer, 1993, 72(4): 1272-1280.

共引文献13

同被引文献5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部